The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
VALOR study: A phase II trial of vorinostat to augment response to 177Lutetium-PSMA-617 in the treatment of patients with PSMA-low metastatic castration resistant prostate cancer.
 
Ruben Raychaudhuri
No Relationships to Disclose
 
Roman Gulati
Employment - Linda Fukuda Family Dentistry (I)
Patents, Royalties, Other Intellectual Property - Royalty for textbook "Statistics for Health Data Science"
(OPTIONAL) Uncompensated Relationships - American Cancer Society
 
Erolcan Sayar
No Relationships to Disclose
 
Andrii Hannochka
No Relationships to Disclose
 
Hiba Khan
No Relationships to Disclose
 
Heather Cheng
Consulting or Advisory Role - Janssen Oncology
Research Funding - Clovis Oncology (Inst); Janssen (Inst); Phosplatin Therapeutics (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Andrew Hsieh
Honoraria - Hotspot Therapeutics
Research Funding - Denali Therapeutics
Patents, Royalties, Other Intellectual Property - MTOR modulators and uses thereof Patent number: 9629843; USE OF TRANSLATIONAL PROFILING TO IDENTIFY TARGET MOLECULES FOR THERAPEUTIC TREATMENT Publication number: 20140288097
 
Jessica Hawley
Employment - Johnson & Johnson/Janssen
Consulting or Advisory Role - Daiichi Sankyo/Lilly; GlaxoSmithKline; ImmunityBio
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Crescendo Biologics (Inst); Janssen Oncology (Inst); Macrogenics (Inst); Vaccitech (Inst)
 
Petros Grivas
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; Foundation Medicine; Fresenius Kabi; Gilead Sciences; Janssen; Merck; Pfizer; Replimune; Roche; Strata Oncology
Research Funding - Acrivon Therapeutics (Inst); ALX Oncology (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); QED Therapeutics (Inst)
 
Rajitha Sunkara
No Relationships to Disclose
 
Rosa Nadal
No Relationships to Disclose
 
Todd Yezefski
Consulting or Advisory Role - Dendreon
 
Evan Yu
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Bristol Myers Squibb; Janssen; Loxo/Lilly; Merck; Oncternal Therapeutics
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); Dendreon (Inst); Lantheus Medical Imaging (Inst); Merck (Inst); Oncternal Therapeutics (Inst); Seagen (Inst); Tyra Biosciences (Inst)
 
Robert Montgomery
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Beigene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst)
 
Joshua Lang
Consulting or Advisory Role - 4D Pharma; 4D Pharma; Arvinas; AstraZeneca; Foundation Medicine; Gilead Sciences; Immunomedics; Janssen; Macrogenics; Pfizer; Pfizer/Astellas; Pfizer/Myovant; Sanofi
Research Funding - Agensys (Inst); Arvinas (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Medivation (Inst)
Patents, Royalties, Other Intellectual Property - I am listed on the patent on a technology for rare cell capture and analysis. This technology has been licensed by Salus Discovery, LLC though no commercial products are available.
 
Delphine Chen
Consulting or Advisory Role - GE Healthcare; Telix Pharmaceuticals
Research Funding - United Imaging
 
Peter Nelson
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Genentech; Janssen Oncology; Pfizer
Research Funding - Janssen Oncology
Expert Testimony - Venable
 
Amir Iravani
Consulting or Advisory Role - Lantheus Medical Imaging; Novartis
 
Michael Haffner
Honoraria - Pfizer
Research Funding - Genentech; Merck; Novartis
 
Michael Schweizer
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; FibroGen; Janssen; Pfizer; Sanofi
Research Funding - Ambrx (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Epigenetix (Inst); Immunomedics (Inst); Incyte (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SignalOne Bio (Inst); Tmunity Therapeutics, Inc. (Inst); Xencor (Inst); Zenith Epigenetics (Inst)